x

Search for a clinical trial

* (*) mandatory field

Study NOG112264: A phase II study of Ozanezumab (GSK1223249) versus placebo in the treatment of Amyotrophic Lateral Sclerosis - DE - Completed

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Glaxosmithkline research & development ltd.
  • Website
  • Principal investigator of clinical trial

  • Pr Susanne PETRI
  • Klinik für Neurologie
  • Medizinische Hochschule Hannover
  • Carl-Neuberg-Str. 1
  • 30625 HANNOVER
  • GERMANY
  • More information
  • Phone  : 49 (0)511 532 3122
  • Fax  : 49 (0)511 532 161082
  • Website
Last update: March 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.